Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pacira Pharmaceuticals

25.97
-0.7700-2.88%
Post-market: 25.970.00000.00%19:42 EDT
Volume:431.59K
Turnover:11.33M
Market Cap:1.20B
PE:-11.45
High:27.18
Open:26.68
Low:25.95
Close:26.74
Loading ...

Kristen Williams, Chief Administrative Officer, Reports Disposal of Common Shares of Pacira Biosciences Inc

Reuters
·
06 Jun

Lauren Riker, Senior Vice President of Finance, Reports Disposal of Common Shares of Pacira Biosciences Inc

Reuters
·
06 Jun

Pacira BioSciences Announces Inducement Grants for New Employees Under Amended 2014 Plan

Reuters
·
05 Jun

Pacira Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
05 Jun

Pacira Biosciences Announces Promising Preliminary Results for Gene Therapy PCRX-201 in Treating Osteoarthritis Knee Pain

Reuters
·
15 May

Pacira BioSciences Inc. to Participate in Analyst-Led Fireside Chat at RBC Capital Markets Global Healthcare Conference

Reuters
·
14 May

Stock Track | Pacira Pharmaceuticals Plummets 7.67% as Q1 Revenue Falls Short of Analyst Expectations

Stock Track
·
09 May

Pacira BioSciences Is Maintained at Buy by Needham

Dow Jones
·
09 May

Pacira Q1 Adjusted Earnings Unchanged; Revenue Rises; 2025 Sales Guidance Steady

MT Newswires Live
·
09 May

Stock Track | Pacira Pharmaceuticals Plunges 7.99% as Q1 Revenue Falls Short of Expectations

Stock Track
·
09 May

Stock Track | Pacira Pharmaceuticals Plunges 7.99% After Q1 Revenue Miss Despite Earnings Beat

Stock Track
·
09 May

Pacira Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Pacira Biosciences Q1 Adjusted EBITDA USD 44.1 Million Vs. IBES Estimate USD 41.2 Million

Reuters
·
09 May

Pacira BioSciences Q1 Adj. EPS $0.62 Beats $0.60 Estimate, Sales $168.92M Miss $176.03M Estimate

Benzinga
·
09 May

Pacira Biosciences Q1 Cash & Investments USD 493.6 Million

THOMSON REUTERS
·
09 May

Pacira Biosciences Inc Says Co Reiterating Its Full-Year 2025 Financial Guidance

THOMSON REUTERS
·
09 May

Pacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee Osteoarthritis

GlobeNewswire
·
02 May

Analysts Estimate Pacira (PCRX) to Report a Decline in Earnings: What to Look Out for

Zacks
·
29 Apr

Pacira to Report First Quarter 2025 Financial Results on Thursday May 8, 2025

GlobeNewswire
·
29 Apr

Pacira BioSciences' Gene Therapy Shows Long-Term Improvement in Knee Osteoarthritis Symptoms

MT Newswires Live
·
28 Apr